Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - TOTAL LIABILITIES
Total Liabilities EBS - Emergent BioSolutions Inc.
1.17 B
LAST VALUE
-6.40%
2 YEAR CAGR
-0.74%
5 YEAR CAGR
23.92%
10 YEAR CAGR